Hmgb1 Silencing in the Amygdala Inhibits Pain-Related Behaviors in a Rat Model of Neuropathic Pain

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Aug 12

PMID 37569320

Authors

Peyton Presto

Guangchen Ji

Olga Ponomareva

Igor Ponomarev

Volker Neugebauer

Affiliations

Soon will be listed here.

Abstract

Chronic pain presents a therapeutic challenge due to the highly complex interplay of sensory, emotional-affective and cognitive factors. The mechanisms of the transition from acute to chronic pain are not well understood. We hypothesized that neuroimmune mechanisms in the amygdala, a brain region involved in the emotional-affective component of pain and pain modulation, play an important role through high motility group box 1 (Hmgb1), a pro-inflammatory molecule that has been linked to neuroimmune signaling in spinal nociception. Transcriptomic analysis revealed an upregulation of Hmgb1 mRNA in the right but not left central nucleus of the amygdala (CeA) at the chronic stage of a spinal nerve ligation (SNL) rat model of neuropathic pain. Hmgb1 silencing with a stereotaxic injection of siRNA for Hmgb1 into the right CeA of adult male and female rats 1 week after (post-treatment), but not 2 weeks before (pre-treatment) SNL induction decreased mechanical hypersensitivity and emotional-affective responses, but not anxiety-like behaviors, measured 4 weeks after SNL. Immunohistochemical data suggest that neurons are a major source of Hmgb1 in the CeA. Therefore, Hmgb1 in the amygdala may contribute to the transition from acute to chronic neuropathic pain, and the inhibition of Hmgb1 at a subacute time point can mitigate neuropathic pain.

Citing Articles

TLR-4: a promising target for chemotherapy-induced peripheral neuropathy.

Babu N, Gadepalli A, Akhilesh , Sharma D, Singh A, Chouhan D Mol Biol Rep. 2024; 51(1):1099.

PMID: 39466456 DOI: 10.1007/s11033-024-10038-1.

Lentivirus-mediated RNA interference targeting HMGB1 modulates AQP1 to reduce pain induced by chronic compression of the dorsal root ganglia.

Li J, Yang K, Yao F, Wei H Front Pharmacol. 2024; 15:1469223.

PMID: 39359252 PMC: 11445020. DOI: 10.3389/fphar.2024.1469223.

Cells and circuits for amygdala neuroplasticity in the transition to chronic pain.

Kiritoshi T, Yakhnitsa V, Singh S, Wilson T, Chaudhry S, Neugebauer B Cell Rep. 2024; 43(9):114669.

PMID: 39178115 PMC: 11473139. DOI: 10.1016/j.celrep.2024.114669.

Single-neuron projectome-guided analysis reveals the neural circuit mechanism underlying endogenous opioid antinociception.

Dou Y, Liu Y, Ding W, Li Q, Zhou H, Li L Natl Sci Rev. 2024; 11(7):nwae195.

PMID: 39045468 PMC: 11264302. DOI: 10.1093/nsr/nwae195.

Ginger Polyphenols Reverse Molecular Signature of Amygdala Neuroimmune Signaling and Modulate Microbiome in Male Rats with Neuropathic Pain: Evidence for Microbiota-Gut-Brain Axis.

Shen C, Santos J, Elmassry M, Bhakta V, Driver Z, Ji G Antioxidants (Basel). 2024; 13(5).

PMID: 38790607 PMC: 11118883. DOI: 10.3390/antiox13050502.

References

Ji G, Neugebauer V . Hemispheric lateralization of pain processing by amygdala neurons. J Neurophysiol. 2009; 102(4):2253-64. PMC: 2776996. DOI: 10.1152/jn.00166.2009. View

Irie Y, Tsubota M, Ishikura H, Sekiguchi F, Terada Y, Tsujiuchi T . Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis. J Neuroimmune Pharmacol. 2017; 12(4):693-707. DOI: 10.1007/s11481-017-9757-2. View

Thompson J, Ji G, Neugebauer V . Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain. Mol Pain. 2015; 11:51. PMC: 4551697. DOI: 10.1186/s12990-015-0055-9. View

Yakhnitsa V, Ji G, Hein M, Presto P, Griffin Z, Ponomareva O . Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain. Front Pharmacol. 2022; 13:903978. PMC: 9177060. DOI: 10.3389/fphar.2022.903978. View

Han J, Adwanikar H, Li Z, Ji G, Neugebauer V . Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Mol Pain. 2010; 6:10. PMC: 2829526. DOI: 10.1186/1744-8069-6-10. View

Thakur V, Sadanandan J, Chattopadhyay M . High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy. Int J Mol Sci. 2020; 21(3). PMC: 7036925. DOI: 10.3390/ijms21030881. View

Klune J, Dhupar R, Cardinal J, Billiar T, Tsung A . HMGB1: endogenous danger signaling. Mol Med. 2008; 14(7-8):476-84. PMC: 2323334. DOI: 10.2119/2008-00034.Klune. View

Xie W, Zhu T, Dong X, Nan F, Meng X, Zhou P . HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways. Biomolecules. 2019; 9(10). PMC: 6843331. DOI: 10.3390/biom9100512. View

Kim S, Chung J . An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992; 50(3):355-363. DOI: 10.1016/0304-3959(92)90041-9. View

10.

Liu J, Li D, Huang J, Cao J, Cai G, Guo Y . Glutamatergic Neurons in the Amygdala Are Involved in Paclitaxel-Induced Pain and Anxiety. Front Psychiatry. 2022; 13:869544. PMC: 9049739. DOI: 10.3389/fpsyt.2022.869544. View

11.

Nakao A, Takahashi Y, Nagase M, Ikeda R, Kato F . Role of capsaicin-sensitive C-fiber afferents in neuropathic pain-induced synaptic potentiation in the nociceptive amygdala. Mol Pain. 2012; 8:51. PMC: 3464693. DOI: 10.1186/1744-8069-8-51. View

12.

Liu J, Hu T, Zhang M, Xu C, Yuan M, Li R . Differential efferent projections of GABAergic neurons in the basolateral and central nucleus of amygdala in mice. Neurosci Lett. 2021; 745:135621. DOI: 10.1016/j.neulet.2020.135621. View

13.

Shibasaki M, Sasaki M, Miura M, Mizukoshi K, Ueno H, Hashimoto S . Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain. 2010; 149(3):514-521. DOI: 10.1016/j.pain.2010.03.023. View

14.

OConnor K, Hansen M, Rachal Pugh C, Deak M, Biedenkapp J, Milligan E . Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine. 2003; 24(6):254-65. DOI: 10.1016/j.cyto.2003.08.001. View

15.

Gregoire S, Neugebauer V . 5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain. Mol Pain. 2013; 9:41. PMC: 3751088. DOI: 10.1186/1744-8069-9-41. View

16.

Fayaz A, Croft P, Langford R, Donaldson L, Jones G . Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016; 6(6):e010364. PMC: 4932255. DOI: 10.1136/bmjopen-2015-010364. View

17.

Liu C, Yang J, Liu H, Xia T, Zhang F . miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models. Genes Genomics. 2019; 42(3):309-316. DOI: 10.1007/s13258-019-00904-9. View

18.

Crock L, Kolber B, Morgan C, Sadler K, Vogt S, Bruchas M . Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain. J Neurosci. 2012; 32(41):14217-26. PMC: 3494864. DOI: 10.1523/JNEUROSCI.1473-12.2012. View

19.

Wen Y, Fan X, Bu H, Ma L, Kong C, Huang C . Downregulation of lncRNA FIRRE relieved the neuropathic pain of female mice by suppressing HMGB1 expression. Mol Cell Biochem. 2020; 476(2):841-852. DOI: 10.1007/s11010-020-03949-7. View

20.

Faraco G, Fossati S, Bianchi M, Patrone M, Pedrazzi M, Sparatore B . High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem. 2007; 103(2):590-603. DOI: 10.1111/j.1471-4159.2007.04788.x. View